Cargando…

The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease

SIMPLE SUMMARY: Aims and objectives: For this study, we hypothesized that the two TSPO ligands CB86 and CB204 can inhibit cellular apoptosis and necrosis by in in vitro cellular PD model of undifferentiated PC12 cells exposed to 6-hydroxydopamine (6-OHDA, 80 µM). The two TSPO ligands CB86 and CB204...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monga, Sheelu, Denora, Nunzio, Laquintana, Valentino, Yashaev, Rami, Weizman, Abraham, Gavish, Moshe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615274/ https://www.ncbi.nlm.nih.gov/pubmed/34827176 http://dx.doi.org/10.3390/biology10111183

Ejemplares similares

The protective effect of the TSPO ligands 2,4-Di-Cl-MGV-1, CB86, and CB204 against LPS-induced M1 pro-inflammatory activation of microglia
por: Monga, Sheelu, et al.
Publicado: (2020)

Efficaciousness of Low Affinity Compared to High Affinity TSPO Ligands in the Inhibition of Hypoxic Mitochondrial Cellular Damage Induced by Cobalt Chloride in Human Lung H1299 Cells
por: Zeineh, Nidal, et al.
Publicado: (2020)

The Efficacy of the Novel TSPO Ligands 2-Cl-MGV-1 and 2,4-Di-Cl-MGV-1 Compared to the Classical TSPO Ligand PK 11195 to Counteract the Release of Chemokines from LPS-Stimulated BV-2 Microglial Cells
por: Monga, Sheelu, et al.
Publicado: (2020)

Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation
por: Monga, Sheelu, et al.
Publicado: (2019)

The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines
por: Amara, Rula, et al.
Publicado: (2022)

The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation
por: Monga, Sheelu, et al.
Publicado: (2022)

Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes
por: Zeineh, Nidal, et al.
Publicado: (2019)

TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation
por: Laquintana, Valentino, et al.
Publicado: (2016)

Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [(18)F]Fluoromethyl-PBR28 and [(18)F]CB251
por: Kim, Ga Ram, et al.
Publicado: (2018)

An Updated View of Translocator Protein (TSPO)
por: Denora, Nunzio, et al.
Publicado: (2017)

Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [(11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [(11)C](R)-PK11195
por: Hatano, Kentaro, et al.
Publicado: (2015)

Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand–Dextran Nanogels
por: Lopalco, Antonio, et al.
Publicado: (2018)

Coupling of CB-2 and CB-1
por: Ansaldo
Publicado: (2003)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Green Fluorescent Terbium (III) Complex Doped Silica Nanoparticles for TSPO Targeting
por: Fanizza, Elisabetta, et al.
Publicado: (2019)

The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
por: Azrad, Maya, et al.
Publicado: (2019)

Editorial: What does it take to cure the brain? Studies toward genes, proteins, processes, and rehabilitation
por: Shu, Xinhua, et al.
Publicado: (2023)

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021)

Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis
por: Vállez Garcia, David, et al.
Publicado: (2015)

CB0 is finished machining, and for CB+1 the shell is finished.
por: P. Fabbricatore
Publicado: (2003)

CB-1 after impregnation ready for coupling with CB-2.
por: Ansaldo
Publicado: (2003)

Situation of CB+1/CB+2 mid January 2004
por: Ansaldo
Publicado: (2004)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice
por: Liu, Xiaojie, et al.
Publicado: (2022)

Preclinical Evaluation of a Novel (99m)Tc-Labeled CB86 for Rheumatoid Arthritis Imaging
por: Liu, Peng, et al.
Publicado: (2020)

CMS CB Meeting
Publicado: (1999)

CMS CB Meeting
Publicado: (1999)

Winding of CB-1
por: P. Fabbricatore
Publicado: (2003)

The CB-ELSA experiment
por: Ehmanns, A
Publicado: (2000)

Determination of $V_{cb}$
por: Calvi, Marta
Publicado: (1999)

News from CB
por: Harnew, N
Publicado: (1999)

CB0 wound
por: Ansaldo
Publicado: (2004)

The TSPO Ligands MGV-1 and 2-Cl-MGV-1 Differentially Inhibit the Cigarette Smoke-Induced Cytotoxicity to H1299 Lung Cancer Cells
por: Zeineh, Nidal, et al.
Publicado: (2021)

Situation of mandrel manufacture (CB-1 & CB0) end of November 2002
por: Ansaldo
Publicado: (2002)

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
por: Bow, Eric W., et al.
Publicado: (2016)

Giant Flexoelectro-optic Effect with Liquid Crystal Dimer CB7CB
por: Varanytsia, Andrii, et al.
Publicado: (2017)

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
por: Bouskila, Joseph, et al.
Publicado: (2016)

Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
por: Brust, Christina A., et al.
Publicado: (2023)

Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic Ligands
por: Veenman, Leo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bt2iltjor03hheekja2c02rmh0